Jason A. Leverone

Insider Reports History

Location
Boulder, CO
Signature
/s/ Jason Leverone
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason A. Leverone:

Company Role Class Num Shares Value Price $ Report Date Ownership
OnKure Therapeutics, Inc. Chief Financial Officer Class A Common Stock 16,301 $48,376 $2.97 22 Dec 2025 Direct
OnKure Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 65,000 27 Jan 2025 Direct

Insider Reports Filed by Jason A. Leverone

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OKUR OnKure Therapeutics, Inc. 22 Dec 2025 1 -$896 4 Chief Financial Officer 23 Dec 2025, 20:08
OKUR OnKure Therapeutics, Inc. 22 Sep 2025 1 -$795 4 Chief Financial Officer 24 Sep 2025, 19:41
OKUR OnKure Therapeutics, Inc. 23 Jun 2025 1 -$722 4 Chief Financial Officer 25 Jun 2025, 18:49
OKUR OnKure Therapeutics, Inc. 04 Apr 2025 2 -$9,178 4 Chief Financial Officer 08 Apr 2025, 17:30
OKUR OnKure Therapeutics, Inc. 27 Jan 2025 1 $0 4 Chief Financial Officer 29 Jan 2025, 20:35
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 4 $0 4 Chief Financial Officer 08 Oct 2024, 19:26
OKUR OnKure Therapeutics, Inc. 04 Oct 2024 0 $0 3 Chief Financial Officer 08 Oct 2024, 19:10